In October, CPP will send money back to members who purchased vaccines from Sanofi, Merck and/or Seqirus between January 1, 2025 and June 30, 2025. Maximize your rebates in 2026 by making sure your purchasing accounts are aligned to your purchasing preferences! 

Simplify Your Rebate Process – Enroll in ACH Today!

CPP can directly deposit your rebate into your checking account, if interested. To enroll, simply complete and submit this ACH authorization form to CPP at cpp@nationwidechildrens.org or fax it to 614-722-2149. You only need to submit the form once.

New Rebates Coming

CPP most recently added rebates for Prevnar 20, Abrysvo, Trumenba, Penbraya, Vaxelis and Beyfortus and now we’re planning on paying rebates to members who purchase Enflonsia from July 1 through December 31! 

The August 28, 2025, edition of the Morbidity and Mortality Weekly Report (MMWR) features information on the use of Enflonsia™ for the prevention of respiratory syncytial virus (RSV).

• Billing Information: Enflonsia™ is billed under CPT code 90382 – Respiratory syncytial virus, monoclonal antibody, seasonal dose, 0.7 mL, for intramuscular use.
• Reimbursement Reminder: We recommend checking with your major payers to confirm reimbursement policies before adding new immunizations to your schedule. Payment for newly approved immunizations typically begins about 90 days after CDC Director approval of ACIP recommendations.

CPP Member Benefits

Enflonsia™ is available at a discounted rate for practices enrolled in the CPP/Merck contract. To enroll or request updated pricing, please contact the CPP office at cpp@nationwidechildrens.org. CPP’s Pediatric and Adult Coding Cheat Sheets have also been updated to include CPT code 90382.